76 related articles for article (PubMed ID: 2215624)
1. HLA-A11-associated resistance to skin cancer in renal-transplant recipients.
Bavinck JN; Kootte AM; van der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
N Engl J Med; 1990 Nov; 323(19):1350. PubMed ID: 2215624
[No Abstract] [Full Text] [Related]
2. HLA-A11 in renal allograft recipients with skin cancer.
McGregor JM; Reddi G; MacDonald D; Vaughan RW; Welsh KI
J Invest Dermatol; 1992 Feb; 98(2):261-2. PubMed ID: 1571047
[No Abstract] [Full Text] [Related]
3. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
4. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
5. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantation.
Bock A; Bliss RL; Matas A; Little JA
Transplantation; 2004 Sep; 78(5):775-8. PubMed ID: 15371688
[TBL] [Abstract][Full Text] [Related]
7. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
8. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
Bavinck JN; Gissmann L; Claas FH; Van der Woude FJ; Persijn GG; Ter Schegget J; Vermeer BJ; Jochmus I; Müller M; Steger G
J Immunol; 1993 Aug; 151(3):1579-86. PubMed ID: 8393047
[TBL] [Abstract][Full Text] [Related]
9. Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome.
La Manna G; Corsini S; Iannelli S; Cappuccilli ML; Comai G; Iorio M; Todeschini P; Carretta E; Scolari MP; Bontadini A; Stefoni S
Ann Transplant; 2013 Nov; 18():611-21. PubMed ID: 24220609
[TBL] [Abstract][Full Text] [Related]
10. HLA phenotypes in patients who have osteosarcoma.
Shimizu T; Chigira M; Nagase M; Watanabe H; Udagawa E
J Bone Joint Surg Am; 1990 Jan; 72(1):68-70. PubMed ID: 2295675
[TBL] [Abstract][Full Text] [Related]
11. HLA antigen distribution in renal transplant recipients and donors.
Tuladhar A; Shrestha S; Raut PP; Bhandari P; Shrestha P
J Nepal Health Res Counc; 2013 Sep; 11(25):289-92. PubMed ID: 24908533
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell chimerism after renal transplantation and vascular rejection.
Lagaaij EL; Cramer-Knijnenburg GF; van Kemenade FJ; van Es LA; Bruijn JA; van Krieken JH
Lancet; 2001 Jan; 357(9249):33-7. PubMed ID: 11197359
[TBL] [Abstract][Full Text] [Related]
13. HLA-A11 is associated with poor prognosis in childhood acute lymphoblastic leukemia (ALL).
Orgad S; Cohen IJ; Neumann Y; Vogel R; Kende G; Ramot B; Zaizov R; Gazit E
Leukemia; 1988 Dec; 2(12 Suppl):79S-87S. PubMed ID: 3199882
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in the development and course of acute lymphoblastic leukemia in children].
Suslova TA; Berlinson MIa; Zhukovskaia EV; Rusanova NN
Pediatriia; 1991; (1):108-9. PubMed ID: 2041683
[No Abstract] [Full Text] [Related]
15. HLA phenotypes in Asians developing tuberculosis on dialysis or after renal transplantation.
John GT; Murugesan K; Jeyaseelan L; Pulimood RB; Jacob CK; Shastry JC
Natl Med J India; 1995; 8(3):144,146. PubMed ID: 7780361
[No Abstract] [Full Text] [Related]
16. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily.
Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG
Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368
[TBL] [Abstract][Full Text] [Related]
18. Anti-human leukocyte antigens and anti-major histocompatibility complex class I-related chain A antibody expression in kidney transplantation during a four-year follow-up.
He J; Li C; Yuan XN; Zhang JL; Li Y; Wei XD; Hou JQ
Chin Med J (Engl); 2013; 126(15):2815-20. PubMed ID: 23924448
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer and HLA antigens.
Czarnecki D; Zalcberg J; Nicholson I; Tait B
N Engl J Med; 1992 Mar; 326(11):765-6. PubMed ID: 1738389
[No Abstract] [Full Text] [Related]
20. HLA linkage of warts and basal cell carcinomas in renal transplant recipients.
Welsh KI; Higgins E; Tidman M; Cameron JS; Koffman CG; Ogg CS; Williams DG
Transplant Proc; 1989 Feb; 21(1 Pt 1):579. PubMed ID: 2495620
[No Abstract] [Full Text] [Related]
[Next] [New Search]
